Another study comparing the performance of GFP-reporter-based pseudotyped virus neutralisation assay versus four commercial immunoassays targeting SARS-CoV-2 S protein yielded results of 100% specificity for COVID-19 diagnosis, and correlation between neutralising antibody titres and SARS-CoV-2 IgG levels [99]. The gene discussed is PROS1; the disease is COVID-19.